More Insights
Healthcare Delivery and Payers Pharmaceuticals and Medical DevicesChallenges
- Healthcare Delivery and Payers
- Pharmaceuticals and Medical Devices
Covid-19 Accelerates the Need for a New Commercial Model
As leadership focuses on the trauma of Covid-19 across healthcare delivery and the challenges it presents, it is easy to forget that the traditional commercial model was under serious stress before the pandemic. Consolidation across delivery, changes in product decision-making, and growing limitations on access were making that model increasingly…
Care Is Migrating to ASC Settings—What’s Your Strategy?
MD+DI
Amidst all the noise about healthcare in the United States, a quiet revolution is reshaping the industry. Care delivery is migrating from inpatient (IP) to outpatient (OP) settings at an accelerating pace. But just because care migration is taking place without much fanfare doesn’t mean device manufacturers should ignore it.…
Design Principles for Value-Based Solutions
Hospitals and healthcare delivery systems are facing significant pressure to improve quality, reduce costs, and increase revenues. As a result, they are putting pressure on medical device manufacturers for lower prices and better outcomes. In addition, they’re introducing other restrictions – like reducing the number of suppliers, limiting physician access,…
What Population Health Means for Manufacturers
It’s no secret that the healthcare industry is under growing pressure to reduce the cost of care while improving quality. Linkage of payment for healthcare to the cost and quality delivered is the idea behind value-based payment frameworks, and is the driving force behind today’s rapidly changing healthcare landscape. Such…
